Drug Landscape ›
saline serum ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 22 April 2025 – 22 April 2026
Total reports: 9
Most-reported reactions
Blood Lactic Acid Increased — 1 report (11.11%) Cerebrovascular Accident — 1 report (11.11%) Dyspnoea — 1 report (11.11%) Erythema — 1 report (11.11%) Flushing — 1 report (11.11%) Hyperventilation — 1 report (11.11%) Local Swelling — 1 report (11.11%) Peripheral Ischaemia — 1 report (11.11%) Swelling Face — 1 report (11.11%)
Source database →
saline serum in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Critical Care / Fluid Management approved in United States
Frequently asked questions
Is saline serum approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for saline serum in United States?
Hédi Chaker Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.